T cell responses to SARS-CoV-2
A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …
Adaptive immune responses and immunity to SARS-CoV-2
Since the onset of the COVID-19 pandemic, the medical field has been forced to apply the
basic knowledge of immunology with the most up-to-date SARS-CoV-2 findings and …
basic knowledge of immunology with the most up-to-date SARS-CoV-2 findings and …
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
T cells specific for SARS-CoV-2 are thought to protect against infection and development of
COVID-19, but direct evidence for this is lacking. Here, we associated whole-blood-based …
COVID-19, but direct evidence for this is lacking. Here, we associated whole-blood-based …
Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
BA Krishna, EY Lim, L Mactavous, PA Lyons… - …, 2022 - thelancet.com
Background There is currently no consensus on the diagnosis, definition, symptoms, or
duration of COVID-19 illness. The diagnostic complexity of Long COVID is compounded in …
duration of COVID-19 illness. The diagnostic complexity of Long COVID is compounded in …
SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants
DB Reeg, M Hofmann, C Neumann-Haefelin… - Pathogens, 2023 - mdpi.com
Adaptive immune responses play an important role in the clinical course of SARS-CoV-2
infection. While evaluations of the virus-specific defense often focus on the humoral …
infection. While evaluations of the virus-specific defense often focus on the humoral …
[HTML][HTML] Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
EC Tallantyre, MJ Scurr, N Vickaryous… - Multiple sclerosis and …, 2022 - Elsevier
Background People with MS treated with anti-CD20 therapies and fingolimod often have
attenuated responses to initial COVID-19 vaccination. However, uncertainties remain about …
attenuated responses to initial COVID-19 vaccination. However, uncertainties remain about …
Healthy immunity on preventive medicine for combating COVID-19
PR Manna, ZC Gray, PH Reddy - Nutrients, 2022 - mdpi.com
Immunomodulation is influenced by the consumption of nutrients, and healthy immunity is
pivotal to defending an individual from a variety of pathogens. The immune system is a …
pivotal to defending an individual from a variety of pathogens. The immune system is a …
Comparison of the immune response in vaccinated people positive and negative to SARS-CoV-2 employing FTIR spectroscopy
GJ Vazquez-Zapien, A Martinez-Cuazitl… - Cells, 2022 - mdpi.com
Various immunopathological events characterize the systemic acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. Moreover, it has been reported that coronavirus …
coronavirus 2 (SARS-CoV-2) infection. Moreover, it has been reported that coronavirus …
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO) …
CS Goodyear, A Patel, E Barnes… - The Lancet …, 2024 - thelancet.com
Background The humoral and T-cell responses to booster COVID-19 vaccine types in
multidisease immunocompromised individuals who do not generate adequate antibody …
multidisease immunocompromised individuals who do not generate adequate antibody …
Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T
S Ambati, B Ali, O Seddon, A Godkin, M Scurr… - International Journal of …, 2023 - Springer
SARS-CoV-2 virus is a single-stranded enveloped RNA virus, which causes coronavirus
disease. Most of the immunocompetent patients with SARS-CoV-2 infection do have mild to …
disease. Most of the immunocompetent patients with SARS-CoV-2 infection do have mild to …